Association Among Polyphenol Intake, Uric Acid, and Hyperuricemia: A Cross-Sectional Analysis in a Population at High Cardiovascular Risk.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
18 10 2022
Historique:
pubmed: 8 10 2022
medline: 21 10 2022
entrez: 7 10 2022
Statut: ppublish

Résumé

Background Dietary polyphenol intake has been associated with a decreased risk of hyperuricemia, but most of this knowledge comes from preclinical studies. The aim of the present study was to assess the association of the intake of different classes of polyphenols with serum uric acid and hyperuricemia. Methods and Results This cross-sectional analysis involved baseline data of 6332 participants. Food polyphenol content was estimated by a validated semiquantitative food frequency questionnaire and from the Phenol-Explorer database. Multivariable-adjusted linear regression models with serum uric acid (milligrams per deciliter) as the outcome and polyphenol intake (quintiles) as the main independent variable were fitted. Cox regression models with constant follow-up time (t=1) were performed to estimate the prevalence ratios (PRs) of hyperuricemia (≥7 mg/dL in men and ≥6 mg/dL in women). An inverse association between the intake of the phenolic acid class (β coefficient, -0.17 mg/dL for quintile 5 versus quintile 1 [95% CI, -0.27 to -0.06]) and hydroxycinnamic acids (β coefficient, -0.19 [95% CI, -0.3 to -0.09]), alkylmethoxyphenols (β coefficient, -0.2 [95% CI, -0.31 to -0.1]), and methoxyphenols (β coefficient, -0.24 [95% CI, -0.34 to -0.13]) subclasses with serum uric acid levels and hyperuricemia (PR, 0.82 [95% CI, 0.71-0.95]; PR, 0.82 [95% CI, 0.71-0.95]; PR, 0.80 [95% CI, 0.70-0.92]; and PR, 0.79 [95% CI, 0.69-0.91]; respectively) was found. The intake of hydroxybenzoic acids was directly and significantly associated with mean serum uric acid levels (β coefficient, 0.14 for quintile 5 versus quintile 1 [95% CI, 0.02-0.26]) but not with hyperuricemia. Conclusions In individuals with metabolic syndrome, a higher intake of some polyphenol subclasses (hydroxycinnamic acids, alkylmethoxyphenol, and methoxyphenol) was inversely associated with serum uric acid levels and hyperuricemia. Nevertheless, our findings warrant further research.

Identifiants

pubmed: 36205262
doi: 10.1161/JAHA.122.026053
pmc: PMC9673670
doi:

Substances chimiques

Uric Acid 268B43MJ25
Polyphenols 0
Coumaric Acids 0
Hydroxybenzoates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e026053

Références

Br J Nutr. 2010 Jun;103(12):1808-16
pubmed: 20102675
Molecules. 2020 Sep 22;25(18):
pubmed: 32971870
Nat Prod Rep. 2009 Aug;26(8):1001-43
pubmed: 19636448
BMJ Open. 2016 Jul 08;6(7):e009809
pubmed: 27401353
Crit Rev Food Sci Nutr. 2019;59(9):1433-1455
pubmed: 29278921
Br J Nutr. 2006 Jul;96(1):191-8
pubmed: 16870009
Nutrients. 2020 Apr 03;12(4):
pubmed: 32260135
BMC Med Res Methodol. 2003 Oct 20;3:21
pubmed: 14567763
Am J Clin Nutr. 2015 Jun;101(6):1113-25
pubmed: 25854881
Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):639-47
pubmed: 24552647
Am J Clin Nutr. 2009 May;89(5):1543S-1548S
pubmed: 19279083
Curr Opin Clin Nutr Metab Care. 2020 Nov;23(6):437-444
pubmed: 32941185
Food Chem. 2017 Jun 15;225:138-145
pubmed: 28193407
Rheumatology (Oxford). 2010 Jan;49(1):141-6
pubmed: 19933595
Pharmazie. 2014 Apr;69(4):243-56
pubmed: 24791587
Database (Oxford). 2010;2010:bap024
pubmed: 20428313
J Ethnopharmacol. 2011 May 17;135(2):399-405
pubmed: 21420478
Int J Biol Macromol. 2016 Dec;93(Pt A):609-614
pubmed: 27616694
Foods. 2020 Jul 23;9(8):
pubmed: 32717824
Cardiovasc Ther. 2020 Apr 24;2020:6719301
pubmed: 32454893
Chin Med J (Engl). 2017 Oct 20;130(20):2473-2488
pubmed: 29052570
Am J Clin Nutr. 2010 Oct;92(4):801-9
pubmed: 20810980
Acta Sci Pol Technol Aliment. 2020 Jan-Mar;19(1):123-131
pubmed: 32227703
Int J Cardiol. 2016 Jun 15;213:8-14
pubmed: 26316329
JAMA. 2019 Oct 15;322(15):1486-1499
pubmed: 31613346
Public Health Nutr. 2010 Sep;13(9):1364-72
pubmed: 20105389
Diabetes Care. 2019 May;42(5):777-788
pubmed: 30389673
Curr Pharm Des. 2019;25(6):700-709
pubmed: 30961478
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Br J Nutr. 1999 Aug;82(2):125-30
pubmed: 10743484
Nutr Metab Cardiovasc Dis. 2015 Feb;25(2):173-80
pubmed: 25511785
Curr Pharm Des. 2018;24(2):239-258
pubmed: 29384050
Rev Esp Cardiol (Engl Ed). 2022 May;75(5):401-411
pubmed: 34340911
Antioxidants (Basel). 2019 Nov 08;8(11):
pubmed: 31717390
Diabetes Care. 2005 Jun;28(6):1390-6
pubmed: 15920057
Am J Clin Nutr. 2010 Oct;92(4):922-7
pubmed: 20739424
Oxid Med Cell Longev. 2009 Nov-Dec;2(5):270-8
pubmed: 20716914
Int J Epidemiol. 1993 Jun;22(3):512-9
pubmed: 8359969
J Agric Food Chem. 2014 Aug 6;62(31):7771-8
pubmed: 25029106
BMC Med. 2014 May 13;12:77
pubmed: 24886552
J Food Biochem. 2020 Feb;44(2):e13111
pubmed: 31849075
PLoS One. 2013;8(2):e56864
pubmed: 23437258
BMC Cardiovasc Disord. 2019 Oct 15;19(1):218
pubmed: 31615412
Semin Arthritis Rheum. 2016 Apr;45(5):580-6
pubmed: 26905267
Public Health Nutr. 2005 Oct;8(7):920-7
pubmed: 16277809
J Pediatr. 2013 May;162(5):896-902
pubmed: 23403249
J Nutr. 2001 Oct;131(10):2741-7
pubmed: 11584098
Nutrients. 2020 Oct 26;12(11):
pubmed: 33114671
Asia Pac J Clin Nutr. 2018;27(6):1344-1356
pubmed: 30485934
J Gerontol A Biol Sci Med Sci. 2013 Oct;68(10):1263-70
pubmed: 23599357
Am J Clin Nutr. 1997 Apr;65(4 Suppl):1220S-1228S; discussion 1229S-1231S
pubmed: 9094926
Arthritis Rheum. 2007 Jun 15;57(5):816-21
pubmed: 17530681
Int J Epidemiol. 2019 Apr 1;48(2):387-388o
pubmed: 30476123
Am J Chin Med. 2008;36(1):149-57
pubmed: 18306458
J Nutr. 2004 Apr;134(4):923-6
pubmed: 15051848
PLoS One. 2017 Jan 13;12(1):e0168148
pubmed: 28085886
Nutrients. 2020 Mar 04;12(3):
pubmed: 32143308
Circulation. 2017 Jun 13;135(24):2369-2372
pubmed: 28606949

Auteurs

María Rubín-García (M)

Group of Investigation in Interactions Gene-Environment and Health (GIIGAS) Institute of Biomedicine (IBIOMED), University of León Spain.

Facundo Vitelli-Storelli (F)

Group of Investigation in Interactions Gene-Environment and Health (GIIGAS) Institute of Biomedicine (IBIOMED), University of León Spain.

Laura Álvarez-Álvarez (L)

Group of Investigation in Interactions Gene-Environment and Health (GIIGAS) Institute of Biomedicine (IBIOMED), University of León Spain.

Miguel Ángel Martínez-González (MÁ)

Department of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Nutrition Harvard T.H. Chan School of Public Health Boston MA.

Jordi Salas-Salvadó (J)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Departament de Bioquímica i Biotecnologia Universitat Rovira i Virgili, Unitat de Nutrició Humana Reus Spain.
University Hospital of Sant Joan de Reus, Servei de Medicina Interna, Unitat de Nutrició Reus Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV) Reus Spain.

Dolores Corella (D)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Preventive Medicine University of Valencia Spain.

Álvaro Hernáez (Á)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Cardiovascular Risk and Nutrition Research Group Institut Hospital del Mar d'Investigacions Mèdiques (IMIM) Barcelona Spain.
Centre for Fertility and Health Norwegian Institute of Public Health Oslo Norway.

J Alfredo Martínez (JA)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Nutrition, Food Sciences, and Physiology University of Navarra Pamplona Spain.
Precision Nutrition Programme IMDEA Food, CEI UAM+CSIC Madrid Spain.

Ángel M Alonso-Gómez (ÁM)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU Vitoria-Gasteiz Spain.

Julia Wärnberg (J)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Nursing, School of Health Sciences University of Malaga Spain.
Instituto de Investigación Biomédica de Málaga-IBIMA Málaga Spain.

Jesús Vioque (J)

CIBER de Epidemiología y Salud Pública (CIBERESP) Instituto de Salud Carlos III Madrid Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernandez (ISABIAL-UMH) Alicante Spain.

Dora Romaguera (D)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Health Research Institute of the Balearic Islands (IdISBa) Palma de Mallorca Spain.

José López-Miranda (J)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC) Reina Sofia University Hospital, University of Cordoba Spain.

Ramon Estruch (R)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Medicine, Faculty of Medicine and Life Sciences University of Barcelona Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS) Barcelona Spain.

Francisco J Tinahones (FJ)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Instituto de Investigación Biomédica de Málaga-IBIMA Málaga Spain.
Department of Endocrinology Virgen de la Victoria Hospital Málaga Spain.

Luís I Serra-Majem (LI)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Research Institute of Biomedical and Health Sciences (IUIBS) University of Las Palmas de Gran Canaria & Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canarian Health Service Las Palmas de Gran Canaria Spain.

Naomi Cano-Ibañez (N)

Instituto de Investigación Biosanitaria ibs.GRANADA Complejo Hospitales Universitarios de Granada/Department of Preventive Medicine and Public Health, University of Granada Spain.

Josep A Tur (JA)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Health Research Institute of the Balearic Islands (IdISBa) Palma de Mallorca Spain.
Research Group on Community Nutrition & Oxidative Stress University of Balearic Islands Palma de Mallorca Spain.

Alba Marcos-Delgado (A)

Group of Investigation in Interactions Gene-Environment and Health (GIIGAS) Institute of Biomedicine (IBIOMED), University of León Spain.

Anna Tresserra-Rimbau (A)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Nutrition, Food Science, and Gastronomy XIA, School of Pharmacy and Food Sciences, INSA, University of Barcelona Spain.

Xavier Pintó (X)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Lipids and Vascular Risk Unit, Internal Medicine Hospital Universitario de Bellvitge, Hospitalet de Llobregat Barcelona Spain.

Miguel Delgado-Rodríguez (M)

Department of Nutrition, Food Sciences, and Physiology University of Navarra Pamplona Spain.
Division of Preventive Medicine, Faculty of Medicine University of Jaén Spain.

Pilar Matía-Martín (P)

Department of Endocrinology and Nutrition Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdISSC) Madrid Spain.

Josep Vidal (J)

CIBER Diabetes y Enfermedades Metabólicas (CIBERDEM) Instituto de Salud Carlos III (ISCIII) Madrid Spain.
Department of Endocrinology Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clinic, University of Barcelona Barcelona Spain.

Clotilde Vázquez (C)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Endocrinology and Nutrition Hospital Fundación Jimenez Díaz, Instituto de Investigaciones Biomédicas IISFJD, University Autonoma Madrid Spain.

Lidia Daimiel (L)

Nutritional Control of the Epigenome Group, Precision Nutrition, and Obesity Program, IMDEA Food CEI UAM+CSIC Madrid Spain.

Emili Ros (E)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Lipid Clinic, Department of Endocrinology and Nutrition Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Hospital Clínic Barcelona Spain.

Zenaida Vázquez-Ruiz (Z)

Department of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.

Nancy Babio (N)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Departament de Bioquímica i Biotecnologia Universitat Rovira i Virgili, Unitat de Nutrició Humana Reus Spain.
University Hospital of Sant Joan de Reus, Servei de Medicina Interna, Unitat de Nutrició Reus Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV) Reus Spain.

Rocío Barragán (R)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Preventive Medicine University of Valencia Spain.

Olga Castañer-Niño (O)

Precision Nutrition Programme IMDEA Food, CEI UAM+CSIC Madrid Spain.

Cristina Razquin (C)

Department of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.

Lucas Tojal-Sierra (L)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU Vitoria-Gasteiz Spain.

Enrique Gómez-Gracia (E)

Instituto de Investigación Biomédica de Málaga-IBIMA Málaga Spain.
Department of Preventive Medicine and Public Health, School of Medicine University of Málaga Spain.

Sandra González-Palacios (S)

CIBER de Epidemiología y Salud Pública (CIBERESP) Instituto de Salud Carlos III Madrid Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernandez (ISABIAL-UMH) Alicante Spain.

Marga Morey (M)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Health Research Institute of the Balearic Islands (IdISBa) Palma de Mallorca Spain.

Antonio García-Rios (A)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Internal Medicine, Maimonides Biomedical Research Institute of Cordoba (IMIBIC) Reina Sofia University Hospital, University of Cordoba Spain.

Sara Castro-Barquero (S)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Department of Medicine, Faculty of Medicine and Life Sciences University of Barcelona Spain.
Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS) Barcelona Spain.

María Rosa Bernal-López (MR)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Instituto de Investigación Biomédica de Málaga-IBIMA Málaga Spain.
Department of Internal Medicine Regional University Hospital of Málaga Spain.

José Manuel Santos-Lozano (JM)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Research Institute of Biomedical and Health Sciences (IUIBS) University of Las Palmas de Gran Canaria & Centro Hospitalario Universitario Insular Materno Infantil (CHUIMI), Canarian Health Service Las Palmas de Gran Canaria Spain.

Miguel Ruiz-Canela (M)

Department of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.
Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.

Antoni Castro-Salomó (A)

University Hospital of Sant Joan de Reus, Servei de Medicina Interna, Unitat de Nutrició Reus Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV) Reus Spain.

Eva Cristina Pascual-Castelló (EC)

Department of Preventive Medicine University of Valencia Spain.

Verónica Moldon (V)

Precision Nutrition Programme IMDEA Food, CEI UAM+CSIC Madrid Spain.

Vanessa Bullón-Vela (V)

Department of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.

Carolina Sorto-Sanchez (C)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Bioaraba Health Research Institute, Osakidetza Basque Health Service, Araba University Hospital, University of the Basque Country UPV/EHU Vitoria-Gasteiz Spain.

Juan Carlos Cenoz-Osinaga (JC)

Department of Preventive Medicine and Public Health Navarra Institute for Health Research (IdiSNA), University of Navarra Pamplona Spain.

Liliana Gutiérrez (L)

University Hospital of Sant Joan de Reus, Servei de Medicina Interna, Unitat de Nutrició Reus Spain.
Institut d'Investigació Sanitària Pere Virgili (IISPV) Reus Spain.

Maira Mengual (M)

Precision Nutrition Programme IMDEA Food, CEI UAM+CSIC Madrid Spain.

Rosa María Lamuela-Raventós (RM)

Centro de Investigación Biomédica en Red Fisiopatología de la Obesidad y la Nutrición (CIBEROBN) Institute of Health Carlos III Madrid Spain.
Lipids and Vascular Risk Unit, Internal Medicine Hospital Universitario de Bellvitge, Hospitalet de Llobregat Barcelona Spain.

Vicente Martín-Sánchez (V)

Group of Investigation in Interactions Gene-Environment and Health (GIIGAS) Institute of Biomedicine (IBIOMED), University of León Spain.
CIBER de Epidemiología y Salud Pública (CIBERESP) Instituto de Salud Carlos III Madrid Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH